
CAS: 1844849-10-0
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | PF 06821497 REF: 3D-UYC84910CAS: 1844849-10-0 | Min. 95% | A consultar | Jue 08 May 25 |
![]() | PF-06821497 REF: TM-T12430CAS: 1844849-10-0 | 97.88% | - - - | Producto descatalogado |

PF 06821497
CAS:1844849-10-0
PF 06821497 is a potential drug for the treatment of Creutzfeldt-Jakob disease (CJD). It is …
Fórmula:
C22H24Cl2N2O5
Pureza:
Min. 95%
Peso molecular:
467.3 g/mol
Ref: 3D-UYC84910
5mg | 1.027,00 € | ||
10mg | 1.344,00 € | ||
25mg | 2.520,00 € | ||
50mg | 4.032,00 € |
Entrega estimada en Estados Unidos, el Jueves 8 de Mayo de 2025

PF-06821497
CAS:1844849-10-0
PF-06821497 is a selective inhibitor of EZH2 with significant tumor growth inhibition.Cost-effective and quality-assured.
Fórmula:
C22H24Cl2N2O5
Pureza:
97.88%
Forma y color:
Solid
Peso molecular:
467.34
Ref: TM-T12430
1mg | Descatalogado | Solicitar información | |
5mg | Descatalogado | Solicitar información | |
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información | |
50mg | Descatalogado | Solicitar información | |
100mg | Descatalogado | Solicitar información | |
200mg | Descatalogado | Solicitar información | |
1ml*10 (DMSO) | Descatalogado | Solicitar información | |
1mL*10mM (DMSO) | Descatalogado | Solicitar información |